Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide in Cutaneous Lupus Erythematosus
NCT00633945Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Nov 2007
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in cutaneous lupus erythematosus (CLE), sponsored by University of Pennsylvania. Started Nov 2007; status: completed.
02
Drugs
lenalidomide
03
Conditions
cutaneous lupus erythematosus (CLE)
Beyond the preview
Go deeper on NCT00633945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00633945.